Lisa VanWagner, MD

2026

• Nov 5–9

  The Liver Meeting 2026 Upcoming

  • Real-World, Data-Driven Strategies to Improve Outcomes in Cirrhosis and Metabolic Disease

  • The Metabolic Dysfunction–Associated Steatotic Liver Disease and Hepatocellular Carcinoma Continuum: Fibrosis, Inflammation, and Clinical Decision-Making, Part 1

  • Personalized Management of Portal Hypertension Across the Lifespan, Part 2

  • MASH: Epidemiology, Natural History, and Outcomes

    Moderator

  • The Editors Cut: Highlights From Liver Transplantation